Does PALBOCICLIB Cause Appetite disorder? 120 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 120 reports of Appetite disorder have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
120
Reports of Appetite disorder with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
5
Deaths
20
Hospitalizations
How Dangerous Is Appetite disorder From PALBOCICLIB?
Of the 120 reports, 5 (4.2%) resulted in death, 20 (16.7%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Appetite disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 120 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Appetite disorder?
SEMAGLUTIDE (187)
LENALIDOMIDE (154)
ADALIMUMAB (113)
PREDNISONE (113)
FUROSEMIDE (111)
NIVOLUMAB (109)
METFORMIN (106)
CABOZANTINIB S-MALATE (100)
ACETAMINOPHEN (93)
ETANERCEPT (92)
Which PALBOCICLIB Alternatives Have Lower Appetite disorder Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID